Results 131 to 140 of about 5,826 (149)

Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study. [PDF]

open access: yesInt J Gynecol Cancer
Graybill WS   +19 more
europepmc   +1 more source

Vaginal stenosis and dilator use after pelvic brachytherapy. [PDF]

open access: yesRev Cuid
Martins da Rosa L   +5 more
europepmc   +1 more source

Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study. [PDF]

open access: yesBMC Cancer
Rubio MJ   +14 more
europepmc   +1 more source

Frequency and factors associated with the preference for self-testing for human papillomavirus detection. [PDF]

open access: yesRev Peru Med Exp Salud Publica
Rosas-Mendoza MA   +2 more
europepmc   +1 more source

Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial. [PDF]

open access: yesGynecol Oncol
Valabrega G   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy